Stock Price
239.95
Daily Change
-3.75 -1.54%
Monthly
-39.57%
Yearly
-63.48%
Q1 Forecast
285.47

Novo Nordisk reported DKK26.89B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Bausch Health Companies USD -112M 291M Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 3.93B 96M Sep/2025
Novo Nordisk DKK 26.89B 388M Dec/2025
Novo Nordisk DKK 4.03B 25.01B Jun/2025
Pacira USD 5.43M 10.28M Sep/2025
Sanofi EUR -801M 3.6B Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025